Next Quarterly Earnings
Friday, October 30, 2026
CW 44
Pre-Market
In 17 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai Pharmaceuticals Holding
Shanghai Pharmaceuticals Holding is a leading integrated pharmaceutical company headquartered in China. Its core business encompasses the research, development, production, and distribution of a wide range of pharmaceuticals and healthcare products. The company is dedicated to innovative medical solutions and enhancing global healthcare.
Frequently asked questions
When will Shanghai Pharmaceuticals Holding report its next quarterly earnings?
Shanghai Pharmaceuticals Holding is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Shanghai Pharmaceuticals Holding last report quarterly earnings?
Shanghai Pharmaceuticals Holding last reported quarterly earnings on 8/27/2026 (Q2 2026). Earnings per share (EPS) came in at 0.67 HKD.
How does Shanghai Pharmaceuticals Holding stock react to earnings?
Across its last 4 earnings reports, Shanghai Pharmaceuticals Holding stock moved by ±0.7% on average the following day. The largest reaction was +1% on 03/30/2026; 3 of 4 reactions were positive.
How often has Shanghai Pharmaceuticals Holding beaten expectations?
Shanghai Pharmaceuticals Holding has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
How do I add the Shanghai Pharmaceuticals Holding earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Stock reaction to earnings
±0.7%
Avg. next-day move
+1%
Largest move (03/30/2026)
75%
Share of positive reactions
±3.2%
Avg. move after 7 days
Basis: price reactions to the last 4 report dates (close to close).
Estimates vs. results
2/3
Quarters above estimates
66.7%
Beat rate
+2.9%
Avg. EPS surprise
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Shanghai Pharmaceuticals Holding
Country
🇨🇳
More Financial Information